Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Common Respiratory Viruses May Accelerate ALS Progression

Study shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).

Chronic Pulmonary Disorders

New Breath and Genetic Testing Project Aims to Diagnose Asthma in Young Children

Researchers are developing a noninvasive diagnostic protocol using breath analysis and cheek swabs to identify asthma before age 5.

Chronic Pulmonary Disorders

Severe Asthma Linked to Measurable Differences in Brain Structure

Patients with severe asthma show structural brain changes and altered neural communication pathways linked to chronic inflammation.

Asthma

California to Send Free Asthma Inhalers to All Public Schools

California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.

COPD

Insurance Barriers Limit Pulmonary Rehab Access

Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.

Cystic fibrosis

Wearable Sweat Test Stickers for Cystic Fibrosis

Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.

Pulmonary Fibrosis

Genetic Scoring Tool May Improve IPF Diagnosis

A study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.

Allergies

How Hurricane Flooding Affects Respiratory Symptoms

Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.

Other Chronic Diseases

Brinsupri/Brensocatib Approved for Bronchiectasis in Japan

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.